U.S. markets close in 5 hours 29 minutes

AVROBIO, Inc. (AVRO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.52+0.20 (+1.72%)
As of 10:30AM EST. Market open.
Sign in to post a message.
  • R
    RalphD
    How does gene therapy compare to protein therapeutics?
    It seems protein therapeutics is an forever treatment for the disease condition such as Gaucher.
    Is the gene therapy approach of $AVRO a one time injection of altered stem cells, and thus superior?

    thx.
  • v
    valuegeek77
    So BLUE debacle brought AVRO down almost 50%

    Now that BLUE is rebounding, AVRO is still left collecting dust.

    Why?
  • T
    Tom
    Clinical results are released this morning and the news is outstanding. Investor update on-line at 8am CT today.
  • J
    Jack Georges
    BLUE trials halt tanking AVRO with it. BLUE is determining how their patient contracted Leukemia 5 years after drug dosing. Wall Street is selling anything that uses the LentilViral gene therapy method
  • B
    Brad
    Is there any difference in the lentil-virii used by BLUE vs. AVRO ? There are subclasses and various strains of retroviruses, even Lentilviruses (I thought). Anyone familiar on this topic, as it's a possible big mistake if everyone is just lumping them altogether and panic selling.
  • S
    Sparky
    Smart money is buying. Good results. Trading at a big discount.
    This will be 20+ in no time.
    Just watch it happen
    AVRO Institutional Ownership - AVROBIO, Inc. Stock
    fintel.io
  • W
    William
    I just bought this stock for the first time on Dec 19. This seems like one of the quieter Yahoo boards, no posts for four days . This seems like a good stock that is underfollowed and been getting beaten up because of BLUE. I thought the trial results from Feb 8th looked very impressive and I like the fact that AVRO probably has around $240M in cash left as of Feb 22nd and no debt. They seem to be burning cash at about $30M per quarter so have enough cash to last them for two years at current burn rate.
  • M
    Muhammad Fitthor
    Very interesting company, got potential to go up 200-300% if the volume go up and it get noticed by the public :D
  • M
    Mike
    What’s going on with Avro today?
  • D
    Dan
    It’s cash less than 250 mm, any possibility to issue new shares to raise cash?
  • B
    Benjamin
    you better load up now where its at. look at the 3 month trend and the 6 month trend 10 to 26. im just saying. LOAD UP NOW. play the 90 days.
  • T
    Tom
    Shares of Amicus Therapeutics Inc. were down 23.1% in premarket trading on Friday, the day after the company said an experimental rare disease drug failed to perform better than the standard of care in a late-stage trial. The investigational drug, AT-GAA, is a treatment for Pompe disease, a rare, genetic disease that causes severe muscle weakness.
    AVROBIO Inc., has a proven technology that will be applied to Pompe disease and yet the stock is down today. This will not last. The Hedge funds short sellers may enjoy the moment but AVROBIO Inc. is the real deal in Lysosomal Storage Disorders disease cures.
  • B
    Benjamin
    BUY AT 10 SELL AT 20.. PLAY THAT GAME. LOOK AT THE CHART. THIS IS A ROTATION OF POWER. BUYERS AND SELLERS.
  • T
    Tom
    One week from today we start getting investigational study results. Be sure to listen to the AVROBIO Virtual Investor Event at the 17th Annual WORLDSymposium™ 2021.
    Feb 8, 2021 from 8:00 AM to 9:30 AM EST
  • v
    valuegeek77
    20 to 11.62 in Five trading days with no material news from company.

    I have never seen anything like this especially in bull market
  • g
    george23
    7 analysts offering 12-month price forecasts for AVROBIO Inc have a median target of 40.00, with a high estimate of 58.00 and a low estimate of 18.00. The median estimate represents a +147.37%.
    BM the rats want cheap shares. Much worser than Reddit. We all hate the hedge funds.
  • R
    RalphD
    $PLX conversation
    I discovered clinical gene therapy company $AVRO. Presentation says they are working on both Fabry and Gaucher disease. Still in ph 1-2. Seems years away from approval.

    But, are they serious competion?
  • v
    valuegeek77
    Utter destruction in the last 5 days from 20 to 11

    Now trading at 6 bucks ex cash, who would have thought 5 days ago.

    This has taken more hit than BLUE.

    Utter non-sense
  • Y
    Yahoo Finance Insights
    Avrobio is down 9.36% to 14.62
  • T
    Tom
    Volume of shares traded lately has been impressive. Who will win the battle between sellers and buyers? There will be only one winner in that confrontation.